Key facts
| Recalling firm | Xiamen Kang Zhongyuan Biotechnology Co., Ltd. |
|---|---|
| Manufacturer | Xiamen Kang Zhongyuan Biotechnology Co., Ltd. |
| Brand name | MGC HEALTH |
| Product description | MGC Health, Menthol- Cough Suppressant, Oral Anesthetic, Cough Drops, Sugar Free, Honey Lemon, 25-count bag, Distributed By: Medical Group Care, LLC, 1035 Collier Center Way, STE 5, Naples, FL 34110, NDC: 83698-125-25, UPC: 383173000085 |
| Classification | Class II |
| Recall number | D-0461-2026 |
| Report date | Not disclosed in the FDA record. |
| Status | Ongoing |
| Reason for recall | This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality. |
What consumers should do
Because this recall carries FDA's middle severity classification, anyone who has this product should stop using it and follow the recalling firm's instructions, even though serious harm is considered unlikely for this classification. Specifically, check whether the product in your possession matches the description on file with FDA -- MGC Health, Menthol- Cough Suppressant, Oral Anesthetic, Cough Drops, Sugar Free, Honey Lemon, 25-count bag, Distributed By: Medical Group Care, LLC, 1035 Collier Center Way, STE 5, Naples, FL 34110, NDC: 83698-125-25, UPC: 383173000085 -- and the recall number D-0461-2026. If it matches, stop using or distributing it and contact Xiamen Kang Zhongyuan Biotechnology Co., Ltd. or the point of purchase for return or replacement instructions. Retailers and distributors holding affected inventory should quarantine it and follow the firm's written recall notice.
What this classification means
FDA classifies a recall as Class II when using the recalled product, or being exposed to it, may cause temporary or medically reversible adverse health consequences, or when the probability of serious adverse health consequences is remote. In this case, the recalling firm is Xiamen Kang Zhongyuan Biotechnology Co., Ltd. and the affected product is described in FDA's record as: MGC Health, Menthol- Cough Suppressant, Oral Anesthetic, Cough Drops, Sugar Free, Honey Lemon, 25-count bag, Distributed By: Medical Group Care, LLC, 1035 Collier Center Way, STE 5, Naples, FL 34110, NDC: 83698-125-25, UPC: 383173000085. FDA's stated reason for the recall is: This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.. The recall is tracked under FDA recall number D-0461-2026 and carries a status of Ongoing as of the most recent FDA enforcement report. This classification reflects FDA's assessment of the product defect described above, not a prediction about any specific patient outcome. FDA maintains a public enforcement report database so that consumers, physicians, and purchasers can look up the exact product identifiers involved before deciding what to do. Recall status can change while FDA and the recalling firm continue corrective actions, so checking the firm's own notice for the most current guidance is recommended.
Xiamen Kang Zhongyuan Biotechnology Co., Ltd.’s FDA history
Argus HQ has recorded 15 total FDA actions tied to Xiamen Kang Zhongyuan Biotechnology Co., Ltd.: 0 warning letters, 15 recalls, 0 approval records, and 0 Form 483 inspection citations.
Frequently asked questions
- What is the current status of this recall?
- Status as recorded by FDA: Ongoing.
- Where can I verify this recall directly with FDA?
- The verbatim FDA record is the source of truth for every recall Argus HQ tracks — always confirm against fda.gov before acting.
- What was recalled and why?
- Xiamen Kang Zhongyuan Biotechnology Co., Ltd. recalled MGC Health, Menthol- Cough Suppressant, Oral Anesthetic, Cough Drops, Sugar Free, Honey Lemon, 25-count bag, Distributed By: Medical Group Care, LLC, 1035 Collier Center Way, STE 5, Naples, FL 34110, NDC: 83698-125-25, UPC: 383173000085. FDA's record states the reason for recall as: This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.. The recall is logged under FDA.
- How serious is this recall?
- FDA classifies a recall as Class II when using the recalled product, or being exposed to it, may cause temporary or medically reversible adverse health consequences, or when the probability of serious adverse health consequences is remote.
Know if this happens again — we'll email you.
Free. No spam, just recall alerts for what you tell us to watch.
Related enforcement actions
Full FDA history for Xiamen Kang Zhongyuan Biotechnology Co., Ltd.Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). FDA Recall Database: Class II Recall: MGC HEALTH by Xiamen Kang Zhongyuan Biotechnology Co., Ltd.. Digital Empire LLC. Retrieved from https://argushq.ai/recall/fda-recall-xiamen-kang-zhongyuan-biotechnology-co-ltd-d-0461-2026
"FDA Recall Database: Class II Recall: MGC HEALTH by Xiamen Kang Zhongyuan Biotechnology Co., Ltd.." Argus HQ Research, Digital Empire LLC, 2026, argushq.ai/recall/fda-recall-xiamen-kang-zhongyuan-biotechnology-co-ltd-d-0461-2026.
Argus HQ Research. "FDA Recall Database: Class II Recall: MGC HEALTH by Xiamen Kang Zhongyuan Biotechnology Co., Ltd.." Digital Empire LLC. Accessed July 13, 2026. https://argushq.ai/recall/fda-recall-xiamen-kang-zhongyuan-biotechnology-co-ltd-d-0461-2026.
@misc{argushq_argushq_ai_recall_fda_recall_xiamen_kang_zhongyuan_biotechnology_co_ltd_d_0461_2026_2026,
title = {FDA Recall Database: Class II Recall: MGC HEALTH by Xiamen Kang Zhongyuan Biotechnology Co., Ltd.},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire LLC},
url = {https://argushq.ai/recall/fda-recall-xiamen-kang-zhongyuan-biotechnology-co-ltd-d-0461-2026},
note = {Accessed: July 13, 2026}
}Source: FDA.gov — Recalls ↗

